SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPetra Diamonds Regulatory News (PDL)

Share Price Information for Petra Diamonds (PDL)

Share Price is delayed by 15 minutes
Get Live Data
7.10    -0.72 (-9.21%)
Bid:
7.10
Ask:
7.48
Spread: 0.38 (5.352%)
Market Cap: £23.81m
PDL Live PriceLast checked at - London Stock Exchange

Intraday Petra Diamonds Share Chart

Board Appointment

10 Feb 2010 07:00

RNS Number : 9136G
Petra Diamonds Ld
10 February 2010
 



 

 

 

 

10 February 2009

 

AIM: PDL

 

 

Petra Diamonds Limited

("Petra" or the "Company")

 

Appointment of Dr. Omar Kamal and retirement of Mr Volker Ruffer

 as Non-Executive Directors

 

 

Petra Diamonds Limited is pleased to announce the appointment of Dr. Omar Kamal as non-executive director of the Company with immediate effect. Dr. Kamal is a Managing Director of Al Rajhi Holdings W.L.L. ("Al Rajhi"), Petra's largest shareholder with 18.1 per cent. of the Company's issued share capital.

 

Petra also announces that Volker Ruffer has retired as non-executive director of the Company with immediate effect. Mr. Ruffer has served on the Petra Board since the Company was admitted to trading on AIM in 1997 and has overseen the development of Petra from an exploration company to a significant rough diamond producer, with a diversified portfolio of six diamond mines. The board would like to thank Mr. Ruffer for his valued input over these important, formative years.

 

The appointment of Dr. Kamal is further to the exercise by Petra of an option to acquire Al Rajhi's 37 per cent. interest in the Cullinan mine (the "Option") announced on 18 December 2009; increasing Petra's direct ownership in the mine to 74 per cent. One of the terms of the Option was the entitlement for Al Rajhi to appoint a director to the Petra board (whilst Al Rajhi's holding in Petra is greater than 10 per cent.). Prior to this, Dr. Kamal served as a Board Member on Cullinan Investment Holdings Limited (the joint venture vehicle that holds Petra's interest in the Cullinan mine) alongside Petra's representatives to the Board.

 

At Al Rajhi, Dr. Kamal is responsible for identifying, managing and participating in strategic investments and joint venture projects. His current portfolio includes investments across various sectors/asset classes such as mining and minerals, financial institutions and international equities.

 

Prior to joining Al Rajhi, Dr. Kamal was Executive Vice President and Head of Investments Group for a Bahrain-based investment/commercial bank with an international reach. He was part of the bank's Executive Committee and served as an active Board Member for a number of companies. His portfolio mainly included real estate assets (in Bahrain and the Asia Pacific Region) and alternative energy related projects (Asia Pacific Region).

 

Prior to that, he headed the Islamic Financial Services Group as a Partner at Ernst & Young. He has been involved in an advisory capacity with leading financial institutions and regulatory bodies to assist in the development of the Islamic finance industry. Dr. Kamal possesses both practical as well as academic experience in Islamic finance.

 

Johan Dippenaar, CEO of Petra, commented on the appointment: "We are delighted to welcome Dr. Kamal to our Board, further cementing our strong partnership with the Al Rajhi group. He brings a wealth of financial expertise to the Company and we look forward to working more closely with him as we continue to develop the Petra group as a leading rough diamond producer."

 

 

Save as set out above and in the Appendix to this release, there is no information in relation to Dr. Kamal's appointment required pursuant to Schedule 2 paragraph (g) of the AIM rules for Companies.

 

~ Ends ~

 

For further information, please contact:

 

Cathy Roberts

Telephone: +44 20 7318 0452

Petra Diamonds, London

cathyr@petradiamonds.com

 

Bobby Morse / James Strong

Telephone: +44 20 7466 5000

Buchanan Communications

bobbym@buchanan.uk.com

jamess@buchanan.uk.com

 

James Duncan / Nicola Taylor

Telephone: +27 11 880 3924

Russell & Associates

james@rair.co.za

nicola@rair.co.za

 

Mike Jones / Ryan Gaffney

Telephone: +44 20 7050 6500

Canaccord Adams

(NOMAD and Joint Broker)

mike.jones@canaccord.com

ryan.gaffney@canaccord.com

 

Joshua Critchley / Martin Eales

Telephone: +44 20 7653 4000

RBC Capital Markets

(Joint Broker)

joshua.critchley@rbccm.com

martin.eales@rbccm.com

 

 

About Petra Diamonds

Petra Diamonds is a leading supplier of rough diamonds. A number of acquisitions have established Petra as one of the world's largest independent diamond groups by resources, with a gross resource base of 262 million carats. Petra increased its annual production fivefold in the year to June 2009 to over 1 million carats and the Company's objective is to continue to increase supply and develop its stature as a world-class diamond group.

 

In South Africa, Petra has interests in five producing mines - Cullinan, Koffiefontein, Helam, Sedibeng and Star - and has also agreed to acquire the Kimberley Underground mines from De Beers (this acquisition is expected to complete soon). In Tanzania, Petra has an interest in the Williamson mine.

 

Petra's mines are noted for the production of valuable diamonds, but in particular the Cullinan mine is famed as the source of the largest gem diamond ever found. More recently, in May 2009 The Star of Josephine, an internally flawless, fancy vivid blue diamond of 7.03 carats from the Cullinan mine, sold for US$9.4 million (US$1.35 million per carat), and in September 2009 The Cullinan Heritage, a white diamond of over 507 carats, was recovered.

 

Petra conducts all its operations according to the highest ethical standards, and will only work in countries which are members of the Kimberley Process.

 

The Company is quoted on the AIM market of the London Stock Exchange (AIM: PDL).

www.petradiamonds.com

 

 

Appendix

 

Information provided in accordance with paragraph (g) of Schedule 2 to the AIM rules:

 

1. Details of full name, age, previous names:

 

Full Name: Dr. Omar Marwan Kamal

 

Age: 37

 

2. Dr. Kamal holds, or has held, the following directorships in the last five years:

 

Current Directorships

None - whilst Dr. Kamal is Managing Director of Al Rajhi Holdings W.L.L., he is not a Board member

 

Previous Directorships

Al Salam Leasing Two Limited.

ASB Biodiesel 1

ASB China 1 Limited

ASB Chatswood Pty Limited

ASB Dee Why Pty Limited

ASBB Pacific Properties Pty Limited

ASBB Pacific Real Estate Holding W.L.L.

Tanjung Penang Villas Sdn Bhd

ASB Biodiesel (Hong Kong) Limited

Manara Developments Company BSC

NS Holding Co. W.L.L.

Cullinan Investment Holdings Limited

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOALLFIDFEIAIII
Date   Source Headline
29th Nov 202411:55 amPRNHolding(s) in Company
29th Nov 202411:55 amPRNHolding(s) in Company
13th Nov 202410:33 amPRNResults of AGM
11th Nov 20247:00 amPRNDirectorate Changes
22nd Oct 20247:00 amPRNQ1 FY 2025 operating update and final sales results for Tenders 1 and 2 FY 2025
15th Oct 20247:00 amPRNNotification of Q1 FY2025 operating update and final sales results for Tenders 1 and 2 FY 2025
14th Oct 20247:00 amPRNPublication of Revised Notice of Annual General Meeting
7th Oct 20247:00 amPRNStrategy/Company/Operations Update
3rd Oct 20247:00 amPRNDirector/PDMR Shareholding
27th Sep 20244:33 pmPRNDirector/PDMR Shareholding
27th Sep 20244:30 pmPRNTR-1: Standard form for notification of major holdings
27th Sep 20247:01 amPRNDirector Share Vesting
27th Sep 20247:00 amPRNDirector Share Awards
24th Sep 20247:01 amPRNAudited Full Year 2024 results
24th Sep 20247:00 amPRNPublication of 2024 Annual Report and 2024 Sustainability Report and Notice of Annual General Meeting
17th Sep 20247:00 amPRNNotice of FY 2024 results (audited)
8th Aug 20247:49 amPRNDirector/PDMR Shareholding
6th Aug 20247:00 amPRNPostponement of Tender 1 FY25
16th Jul 20247:00 amPRNQ4 and FY 2024 Operating Update
9th Jul 20247:00 amPRNNotification of Q4 and FY 2024 Operating Update
4th Jul 20247:00 amPRNSales results for Tender 7 FY 2024
27th Jun 20247:00 amPRNCompany update and appointment of Chief Financial Officer
12th Jun 20247:00 amPRNNotification of Investor Day 2024
10th Jun 20247:00 amPRNConclusion of wage agreement with the NUM in South Africa
23rd May 20247:00 amPRNEntry into long-term Power Purchase Agreements for renewable energy procurement
20th May 20241:48 pmPRNDirector/PDMR Shareholding
17th May 20247:00 amPRNSales results for Tender 6 FY 2024
16th Apr 20247:00 amPRNQ3 FY 2024 Operating Update and Final Sales Results for Tender 5 FY 2024
9th Apr 20247:00 amPRNNotification of Q3 FY 2024 Operating Update
8th Apr 20247:00 amPRNCost savings target increased to more than US$30m per annum and entry into definitive transaction agreement for the sale of Koffiefontein.
8th Mar 20247:23 amPRNDirectorate Change
20th Feb 20247:00 amRNSH1 FY 2024 Interim Results
16th Feb 20247:00 amRNSFinal sales results for Tender 4 FY 2024
13th Feb 20247:00 amRNSNotification of H1 FY 2024 Interim Results
18th Jan 20247:00 amRNSDirector Share Awards
16th Jan 20247:00 amRNSH1 FY 2024 Operating Update
10th Jan 20247:00 amRNSNotification of H1 FY 2024 Operating Update
21st Dec 202310:40 amRNSDirectorate Change
20th Dec 20237:00 amRNSBoard Changes
14th Dec 20237:00 amRNSFinal sales results for Tender 3 FY 2024
13th Dec 202310:47 amRNSPotential Sale of Koffiefontein
8th Dec 20231:00 pmRNSHolding(s) in Company
8th Dec 202311:23 amRNSListing Rule 9.6.14 (R) Disclosure
8th Dec 20237:00 amRNSApproval of increase in Revolving Credit Facility
8th Dec 20237:00 amRNSInitial sales results for Tender 3 FY 2024
6th Dec 202312:25 pmRNSHolding(s) in Company
14th Nov 202311:06 amRNSResult of AGM
13th Nov 20232:45 pmRNSDirectorate Change
8th Nov 20234:03 pmRNSDirector/PDMR Shareholding
1st Nov 20237:00 amRNSImproved resilience through capital deferrals

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.